Melatonin ameliorates cisplatin-induced asthenozoospermia via reducing oxidative stress
1Department of Urology, the Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, China
2Department of Reproduction, the affiliated Obstetrics and Gynecology Hospital with Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, 210029 Nanjing, Jiangsu, China
3Department of Reproduction, the Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, China
DOI: 10.31083/jomh.2021.127 Vol.18,Issue 1,January 2022 pp.1-9
Submitted: 16 July 2021 Accepted: 17 August 2021
Published: 31 January 2022
Background and objective: Cisplatin is an alkylating agent that has become a first-line therapy for some tumors. However, overproduction of reactive oxygen species (ROS) by cisplatin can cause male infertility, which can affect patients' quality of life. Melatonin, which has the ability to provide resistance against oxidation, is a potential therapy for male infertility caused by cisplatin.
Material and methods: Normal human spermatozoa samples were divided into (i) control group incubated with physiological saline solution; (ii) cisplatin group incubated with cisplatin; (iii) melatonin group incubated with melatonin; and (iv) melatonin + cisplatin group incubated with melatonin and cisplatin. Spermatozoa motility was measured using a computer-aided semen analysis system. Additionally, we determined spermatozoa apoptosis through terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. The mitochondrial membrane potential (∆Ψm) and levels of ATP, ROS, and malondialdehyde, as a metabolite of oxidative stress, were measured to study the mechanism by which melatonin can protect human spermatozoa.
Results: Melatonin improved sperm motility, and decreased apoptosis and increased the ∆Ψm value and level of ATP in sperm. More importantly, the overproduction of ROS induced by cisplatin was reduced by melatonin. Furthermore, western blotting revealed that melatonin increased the expression of antioxidant pathway components nuclear factor erythroid 2-related factor (Nrf2) and heme oxygenase-1 (HO-1) that was reduced by cisplatin.
Conclusion: Our studies suggested that melatonin might protect human spermatozoa against the effects of cisplatin through Nrf2/HO-1.
Asthenozoospermia; Melatonin; Cisplatin; Sperm motility; ROS; Human sperm; Nrf2
Yunpeng Shao,Qiao Zhou,Jun Xue,Baixin Shen,Juan Ji,Zhongqing Wei. Melatonin ameliorates cisplatin-induced asthenozoospermia via reducing oxidative stress. Journal of Men's Health. 2022. 18(1);1-9.
 Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. European Journal of Pharmacology. 2014; 740: 364–378.
 Samplaski MK, Nangia AK. Adverse effects of common medications on male fertility. Nature Reviews Urology. 2015; 12: 401–413.
 Fong CW. Platinum anti-cancer drugs: Free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect. Free Radical Biology and Medicine. 2016; 95: 216–229.
 Ateşşahin A, Sahna E, Türk G, Ceribaşi AO, Yilmaz S, Yüce A, et al. Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. Journal of Pineal Research. 2006; 41: 21–27.
 Sikka SC. Oxidative stress and role of antioxidants in normal and abnormal sperm function. Frontiers in Bioscience. 2006; 1: e78–e86.
 Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Rama-lingam SS, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE. 2013; 8: e81162.
 Chai R, Chen G, Shi H, O W, Martin-DeLeon PA, Chen H. Prohibitin involvement in the generation of mitochondrial superoxide at complex I in human sperm. Journal of Cellular and Molecular Medicine. 2017; 21: 121–129.
 Eberl M, Schuppe H-, Kohn F-, Schill W-. Effect of two complex platinum salts on human sperm motility and acrosome reaction. Andrologia. 2000; 32: 303–310.
 Parlakpinar H, Sahna E, Ozer MK, Ozugurlu F, Vardi N, Acet A. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. Journal of Pineal Research. 2002; 33: 161–166.
 Reiter RJ, Tan D, Sainz RM, Mayo JC, Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. The Journal of Pharmacy and Pharmacology. 2002; 54: 1299–1321.
 Saeedan AS, Soliman GA, Abdel-Rahman RF, Abd-Elsalam RM, Ogaly HA, Foudah AI, et al. Artemisia judaica L. diminishes diabetes-induced reproductive dysfunction in male rats via activation of Nrf2/HO-1-mediated antioxidant responses. Saudi Journal of Biological Sciences. 2021; 28: 1713–1722.
 Shi S, Lei S, Tang C, Wang K, Xia Z. Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway. Bioscience Reports. 2019; 39: BSR20181614.
 Gimeno-Martos S, Casao A, Yeste M, Cebrián-Pérez JA, Muiño-Blanco T, Pérez-Pé R. Melatonin reduces cAMP-stimulated capacita-tion of ram spermatozoa. Reproduction, Fertility and Development. 2019; 31: 420.
 Nagata O, Nakamura M, Sakimoto H, Urata Y, Sasaki N, Shiokawa N, et al. Mouse model of chorea-acanthocytosis exhibits male infertility caused by impaired sperm motility as a result of ultrastructural morphological abnormalities in the mitochondrial sheath in the sperm midpiece. Biochemical and Biophysical Research Communications. 2018; 503: 915–920.
 Shao YP, Zhou Q, Li YP, Zhang SC, Xu HW, Wu S, et al. Curcumin ameliorates cisplatin-induced cystopathy via activating NRF2 pathway. Neurourology and Urodynamics. 2018; 37: 2470–2479.
 Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. Journal of Pineal Research. 2000; 28: 73–80.
 Calls A, Torres-Espin A, Navarro X, Yuste VJ, Udina E, Bruna J. Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response. Neuro-Oncology. 2021; 23: 88–99.
 Meena R, Kumari K, Kumar J, Rajamani P, Verma HN, Kesari KK. Therapeutic approaches of melatonin in microwave radiations-induced oxidative stress-mediated toxicity on male fertility pattern of Wistar rats. Electromagnetic Biology and Medicine. 2014; 33: 81–91.
 Huang F, Ning H, Xin Q, Huang Y, Wang H, Zhang Z, et al. Melatonin pretreatment attenuates 2-bromopropane-induced testicular toxicity in rats. Toxicology. 2009; 256: 75–82.
 Li B, He X, Zhuang M, Niu B, Wu C, Mu H, et al. Melatonin Ameliorates Busulfan-Induced Spermatogonial Stem Cell Oxidative Apoptosis in Mouse Testes. Antioxidants & Redox Signaling. 2018; 28: 385–400.
 Kelnar CJH, McKinnell C, Walker M, Morris KD, Wallace WHB, Saunders PTK, et al. Testicular changes during infantile ’quiescence’ in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy? Human Reproduction. 2002; 17: 1367–1378.
 Smart E, Lopes F, Rice S, Nagy B, Anderson RA, Mitchell RT, et al. Chemotherapy drugs cyclophosphamide, cisplatin and doxorubicin induce germ cell loss in an in vitro model of the prepubertal testis. Scientific Reports. 2018; 8: 1773.
 Wang C, Xia Y, Nie J, Zhou M, Zhang R, Niu L, et al. Musca domestica larva lectin induces apoptosis in BEL-7402 cells through a Ca(2+)/JNK-mediated mitochondrial pathway. Cell Biochemistry and Biophysics. 2013; 66: 319–329.
 Jiang L, Cheng L, Kong S, Yang Y, Shen Y, Chen C, et al. Toxic effects of polychlorinated biphenyls (Aroclor 1254) on human sperm motility. Asian Journal of Andrology. 2017; 19: 561–566.
 Bejarano I, Monllor F, Marchena AM, Ortiz A, Lozano G, Jiménez MI, et al. Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa. Journal of Pineal Research. 2014; 57: 333–339.
 Pereira R, Sá R, Barros A, Sousa M. Major regulatory mechanisms involved in sperm motility. Asian Journal of Andrology. 2017; 19: 5–14.
 Delamirande E, Cagnon C. Human sperm hyperactivation and capacitation as parts of an oxidative process. Free Radical Biology and Medicine. 1993; 14: 157–166.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)
Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.
Scopus CiteScore 0.7 (2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).